Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline J Coats

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Heart (British Cardiac Society)|April 23, 2022
History of the British Cardiovascular SocietyCaroline J Coats
International Journal of Cardiology|June 21, 2018
The vital role of exercise testing in hypertrophic cardiomyopathyCaroline J Coats
Current Treatment Options in Cardiovascular Medicine|November 26, 2008
Current management of hypertrophic cardiomyopathyCaroline J Coats, Perry M Elliott
Biomarkers in Medicine|August 3, 2013
Genetic biomarkers in hypertrophic cardiomyopathyCaroline J Coats, Perry M Elliott
Circulation. Heart Failure|August 1, 2024
New Perspectives on Early Stage Hypertrophic Cardiomyopathy: Measuring What MattersFraser C Goldie, Caroline J Coats
JAMA Cardiology|June 13, 2019
Hypertrophic Cardiomyopathy-Need for Gene-Specific Treatment?-ReplyCaroline J Coats, Michael P Frenneaux, Perry M Elliott
British Journal of Hospital Medicine (London, England : 2005)|March 26, 2025
A Case of Left-Dominant Arrhythmogenic Cardiomyopathy Presenting with Cardiac ArrestSimran Piya, Alice Jackson, Caroline J Coats, et al.
European Heart Journal. Case Reports|March 20, 2026
Still at sea: a patient's ongoing journey with non-obstructive hypertrophic cardiomyopathyFraser C Goldie, Rachel C Myles, Caroline J Coats
The New England Journal of Medicine|August 14, 2024
Aficamten for Obstructive Hypertrophic Cardiomyopathy. ReplyMartin S Maron, Caroline J Coats, Daniel L Jacoby
JACC. Cardiooncology|January 11, 2024
Reply: Cardiotoxicity of BRAF/MEK Inhibitors According to HFA/ICOS Cardiotoxicity Risk CategoryClaire Glen, Sarah Adam, Caroline J Coats, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Heart (British Cardiac Society)|April 23, 2022
History of the British Cardiovascular SocietyCaroline J Coats
International Journal of Cardiology|June 21, 2018
The vital role of exercise testing in hypertrophic cardiomyopathyCaroline J Coats
Current Treatment Options in Cardiovascular Medicine|November 26, 2008
Current management of hypertrophic cardiomyopathyCaroline J Coats, Perry M Elliott
Biomarkers in Medicine|August 3, 2013
Genetic biomarkers in hypertrophic cardiomyopathyCaroline J Coats, Perry M Elliott
Circulation. Heart Failure|August 1, 2024
New Perspectives on Early Stage Hypertrophic Cardiomyopathy: Measuring What MattersFraser C Goldie, Caroline J Coats
JAMA Cardiology|June 13, 2019
Hypertrophic Cardiomyopathy-Need for Gene-Specific Treatment?-ReplyCaroline J Coats, Michael P Frenneaux, Perry M Elliott
British Journal of Hospital Medicine (London, England : 2005)|March 26, 2025
A Case of Left-Dominant Arrhythmogenic Cardiomyopathy Presenting with Cardiac ArrestSimran Piya, Alice Jackson, Caroline J Coats, et al.
European Heart Journal. Case Reports|March 20, 2026
Still at sea: a patient's ongoing journey with non-obstructive hypertrophic cardiomyopathyFraser C Goldie, Rachel C Myles, Caroline J Coats
The New England Journal of Medicine|August 14, 2024
Aficamten for Obstructive Hypertrophic Cardiomyopathy. ReplyMartin S Maron, Caroline J Coats, Daniel L Jacoby
JACC. Cardiooncology|January 11, 2024
Reply: Cardiotoxicity of BRAF/MEK Inhibitors According to HFA/ICOS Cardiotoxicity Risk CategoryClaire Glen, Sarah Adam, Caroline J Coats, et al.
Pageof 6